The Economic Times

Donald Trump's drugmaker deals may save economy $529 billion over 10 years: White House

President Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription drug prices to match those in other developed nations. The White House estimates over $500 billion in savings over the next decade. This policy is a key focus for the upcoming midterm elections. Democrats have expressed skepticism about the claimed savings.